Form 483

PharmaCare US Inc. Form 483, 2022-09-02

FDA issued a Form 483 to PharmaCare US Inc. on 2022-09-02 with 2 public-safe observations.

483· Form 483 issuedFoods & Cosmetics2 observations

PharmaCare US Inc. · San Diego, United States · Issued September 2, 2022

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Sep 2022
21 CFR 1.511(c)(5)(i)(A)(4)

No CGMPs - record onsite audit

Cited by Kim A Bellama

2 Sep 2022
21 CFR 1.511(c)(5)(i)(B)

No CGMPs - sampling, testing

Cited by Kim A Bellama

Inspected site

PUPharmaCare US Inc.San Diego, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1.511(c)(5)(i)(A)(4)Cited across public-safe Form 483 observations1x
21 CFR 1.511(c)(5)(i)(B)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere